Summit X LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-288
| Closed | -$303K | – | 232 |
|
|
2024
Q3 | $303K | Sell |
288
-5
| -2% | -$5.26K | 0.07% | 157 |
|
|
2024
Q2 | $308K | Buy |
293
+5
| +2% | +$5.26K | 0.07% | 173 |
|
|
2024
Q1 | $277K | Sell |
288
-546
| -65% | -$526K | 0.07% | 165 |
|
|
2023
Q4 | $732K | Sell |
834
-18
| -2% | -$15.8K | 0.21% | 90 |
|
|
2023
Q3 | $702K | Sell |
852
-9
| -1% | -$7.41K | 0.22% | 87 |
|
|
2023
Q2 | $619K | Sell |
861
-73
| -8% | -$52.5K | 0.15% | 139 |
|
|
2023
Q1 | $767K | Sell |
934
-12
| -1% | -$9.86K | 0.2% | 109 |
|
|
2022
Q4 | $559K | Sell |
946
-1
| -0.1% | -$591 | 0.16% | 140 |
|
|
2022
Q3 | $654K | Buy |
947
+1
| +0.1% | +$691 | 0.19% | 116 |
|
|
2022
Q2 | $558K | Sell |
946
-91
| -9% | -$53.7K | 0.16% | 140 |
|
|
2022
Q1 | $720K | Sell |
1,037
-732
| -41% | -$508K | 0.18% | 119 |
|
|
2021
Q4 | $1.12M | Sell |
1,769
-64
| -3% | -$40.4K | 0.26% | 90 |
|
|
2021
Q3 | $1.11M | Sell |
1,833
-519
| -22% | -$315K | 0.28% | 84 |
|
|
2021
Q2 | $1.31M | Buy |
2,352
+20
| +0.9% | +$11.1K | 0.33% | 70 |
|
|
2021
Q1 | $1.1M | Buy |
2,332
+635
| +37% | +$299K | 0.3% | 81 |
|
|
2020
Q4 | $810K | Buy |
1,697
+927
| +120% | +$442K | 0.24% | 100 |
|
|
2020
Q3 | $39.7K | Buy |
770
+26
| +3% | +$1.34K | 0.65% | 31 |
|
|
2020
Q2 | $464K | Sell |
744
-219
| -23% | -$137K | 0.17% | 128 |
|
|
2020
Q1 | $465K | Buy |
963
+5
| +0.5% | +$2.41K | 0.22% | 107 |
|
|
2019
Q4 | $361K | Sell |
958
-142
| -13% | -$53.5K | 0.13% | 180 |
|
|
2019
Q3 | $310K | Buy |
1,100
+54
| +5% | +$15.2K | 0.12% | 191 |
|
|
2019
Q2 | $309K | Buy |
1,046
+189
| +22% | +$55.8K | 0.13% | 191 |
|
|
2019
Q1 | $352K | Buy |
+857
| New | +$352K | 0.15% | 172 |
|